Vor Biopharma Inc.VOR
Price (close)
$18.44
Market cap
$1.0B
P/E
1.6x
Revenue (TTM)
—
Net income
$627.8M
Dividend yield
—
1-year total return
-45.5%
Net margin
—
Revenue growth
—
Debt / equity
—
What Vor Biopharma Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net income | -$43.3M | -$68.9M | -$92.1M | -$117.9M | -$116.9M | -$696.0M |
| Free cash flow | -$40.5M | -$73.0M | -$93.6M | -$101.4M | -$99.9M | -$143.7M |
More on VOR.
- Vor Biopharma Inc. summary
- Vor Biopharma Inc. financial statements
- Vor Biopharma Inc. key metrics
- Vor Biopharma Inc. health scores and style box
- Vor Biopharma Inc. earnings
- Vor Biopharma Inc. dividends
- Vor Biopharma Inc. valuation
- Vor Biopharma Inc. ownership and insiders
- Vor Biopharma Inc. peers
Figures from Vor Biopharma Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.